Osteogenic lineage commitment of mesenchymal stem cells is the research focus and the frontier of regenerative medicine of bone repair. Our previous studies have found that the expression profile of long non-coding RNAs was altered when the umbilical cord mesenchymal stem cells (hUC-MSCs) commit osteogenic differentiation. Among those, a long non-coding RNA, ODIR1 (osteogenic differentiation inhibitory RNA 1,briefly named as Lnc ODIR1) was significantly down-regulated. Knockdown of Lnc ODIR1 promotes the osteogenesis of MSCs. Over-expression of Lnc ODIR1 decreases the expression of osterix, a specific activated transcription factor in osteoblasts and inhibits osteogenesis of MSCs. RNA-pull down assay combined with mass spectrometry analysis and Western Blot analysis confirmed that Lnc ODIR1 was bound to histone H2A, H2B, H4, and ubiquitination-associated protein FBXO25, BARD1, CUL3 and methylation-associated protein ZNF518A. Therefore, it is proposed that Lnc ODIR1 regulates the osterix-mediated osteogenic differentiation of hUC-MSCs through controlling histone modification. This project aims to further explore how Lnc ODIR1 affects histone H2A/H2B ubiquitination through FBXO25, BARD1 and CUL3 and methylation of histone H4 through ZNF518A, thereby inhibiting the transcriptional osterix during osteogenic differentiation of MSCs with a series of new advanced technologies(CRISPR, CHIRP and CLIP,etc). The implementation of this project supports that knockdown Lnc ODIR1 in mesenchymal stem cells promotes the osteogenic differentiation, which provides novel ideas and strategies for the treatment of bone defects and osteogenic disorders.
诱导干细胞定向成骨分化是骨再生医学领域的研究前沿。申请人前期研究发现间充质干细胞诱导成骨分化时LncRNA表达谱发生改变,尤其是Lnc ODIR1显著下调,敲低其表达可通过上调成骨特异性转录因子Osterix促进成骨,而过表达则抑制成骨分化;并能结合组蛋白H2A,H2B和H4及泛素连接酶FBXO25、CUL3、BARD1和甲基转移酶ZNF518A,因此提出了Lnc ODIR1可能通过组蛋白修饰影响Osterix调控干细胞成骨分化的科学假说。本项目拟利用CRISPR/Cas9敲低、CHIRP和CLIP等新技术研究Lnc ODIR1如何招募FBXO25、CUL3和BARD1调控组蛋白H2A/H2B的泛素化和招募ZNF518A调控组蛋白H4的甲基化进而影响Osterix表达,提出通过敲低Lnc ODIR1的表达水平促进成骨分化的策略,将为再生医学领域骨缺损修复和成骨障碍性疾病的治疗提供新的思路。
在自然科学基金委的资助下,申请人承担的项目“LncRNA ODIR1通过组蛋白修饰调控OSX参与干细胞成骨分化的机制研究”,以LncRNA ODIR1为切入点,从细胞模型、分子水平以及实验动物等不同层面,查明了LncRNA ODIR1抑制干细胞成骨分化的作用机制;发现了LncRNA ODIR1与CUL3和FBXO25结合并且可能通过招募E3泛素连接酶CUL3促进FBXO25的泛素化降解从而下调FBXO25蛋白水平;发现了FBXO25通过调控H2BK120ubi和H3K4me3在OSX启动子出的富集来促进OSX的表达从而调控成骨分化;明确了LncRNA ODIR1体内抑制成骨分化的作用。本项目的研究结果提示敲低Lnc ODIR1表达水平促进成骨分化的策略,为再生医学领域骨缺损修复和成骨障碍性疾病的治疗提供了新的思路。目前相关研究成果发表SCI研究论文10篇,代表性论文发表在Cell Death Dis等国际期刊;授权国家专利8项;参与出版专著1部;培养研究生6名(2人获得国家研究生奖学金);获奖4项。
{{i.achievement_title}}
数据更新时间:2023-05-31
DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素
农超对接模式中利益分配问题研究
低轨卫星通信信道分配策略
中国参与全球价值链的环境效应分析
转录组与代谢联合解析红花槭叶片中青素苷变化机制
USP22去泛素化修饰Osterix调控间充质干细胞成骨分化
组蛋白乙酰化修饰对牙髓细胞成骨/成牙本质分化的调控初探
模拟失重下lncRNA-5233参与骨髓间充质干细胞成骨向分化的功能与机制研究
lncRNA LINC00473靶向miRNA-23a调控骨髓间充质干细胞成骨成脂分化机制研究